Form 8-K - Current report:
SEC Accession No. 0001558370-24-009642
Filing Date
2024-07-01
Accepted
2024-07-01 16:15:15
Documents
13
Period of Report
2024-06-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrmy-20240627x8k.htm   iXBRL 8-K 46634
  Complete submission text file 0001558370-24-009642.txt   167096

Data Files

Seq Description Document Type Size
2 EX-101.SCH hrmy-20240627.xsd EX-101.SCH 3295
3 EX-101.LAB hrmy-20240627_lab.xml EX-101.LAB 15925
4 EX-101.PRE hrmy-20240627_pre.xml EX-101.PRE 10078
15 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20240627x8k_htm.xml XML 4879
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

EIN.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39450 | Film No.: 241090780
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)